genprowebdirectory
News
Insights
A-Lists
Topics
Bioprocessing
Cancer
Drug Discovery
OMICs
Translational Medicine
Genome Editing
Magazine
Resources
Posters
Videos
Webinars
eBooks
Podcasts
Events
New Products
Tutorial
Best of the Web
Best Apps
BioPerspectives
Subscribe
Create a Free Account
Log In
Get GEN Magazine
Get GEN eNewsletters
Get the GEN Mobile App
Get GEN News from Alexa
Search
Search
Advertising
Magazine Advertising
Website Banner Advertising
eNewsletter Advertising
Webinar Sponsorship
eBook Advertising
Email Nurture Campaigns
Ad Terms and Conditions
About GEN
Contact GEN
Create a Free Account
Log In
GEN – Genetic Engineering and Biotechnology News
Mary Ann Liebert, Inc. Publishers
News
News
Mitral Valve Prolapse Caused by Cilia Defects
News
Liquid Biopsies May Simplify Checkups of Transplanted Stem Cells
News
Taking Brakes off Bad Fat to Good Fat Conversion Could Lead…
News
Ground Control to Major Microbe: New Method IDs Bacteria in Space
News
He Jiankui Research Prompts U.S. Academies, U.K. Society to Create Germline…
Insights
Insights
NIH Solicits Research into Vaccines to Protect against Opioid Use
Neuroscience
Human-Derived Brain Models
Artificial Intelligence
Hey Google. Is This Lung Cancer?
Gene Therapy
25 Up-and-Coming Gene Therapies of 2019
Tech Exclusives
Rising to the Challenge of Intensifying Bioprocesses
A-Lists
Gene Therapy
25 Up-and-Coming Gene Therapies of 2019
A-Lists
Top 10 Under 40 of 2019
Insights
Top 10 Best-Selling Cancer Drugs of 2018
Insights
Top 10 Sequencing Companies
May 2019 Vol. 39 No. 5
Top 10 Immuno-Oncology Collaborations
Topics
All
Bioprocessing
Cancer
Drug Discovery
OMICs
Translational Medicine
Genome Editing
News
Liquid Biopsies May Simplify Checkups of Transplanted Stem Cells
News
Taking Brakes off Bad Fat to Good Fat Conversion Could Lead…
News
Ground Control to Major Microbe: New Method IDs Bacteria in Space
Insights
NIH Solicits Research into Vaccines to Protect against Opioid Use
Magazine
May 2019 Vol. 39 No. 5
A Scalable Adenovirus Production Process from Cell Culture to Purified Bulk…
May 2019 Vol. 39 No. 5
Genomics’ “Green” Future
May 2019 Vol. 39 No. 5
Crafting a More Efficient CAR T-Cell Industry
May 2019 Vol. 39 No. 5
All About That Base Editing
May 2019 Vol. 39 No. 5
Signs, Portents, and Immuno-Oncology Biomarkers
Resources
All
Posters
Videos
Webinars
eBooks
Podcasts
Events
New Products
Tutorial
Best of the Web
Best Apps
BioPerspectives
Podcasts
GENcast: Explore, Learn, and Collaborate on Viral Safety in Biomanufacturing
May 2019 Vol. 39 No. 5
A Scalable Adenovirus Production Process from Cell Culture to Purified Bulk…
Upcoming Webinars
Recent Advances and the Future of Antibody Engineering
Videos
3D Bioprinted Organ Just Took Its First “Breath”
Subscribe
Create a Free Account
Log In
Get GEN Magazine
Get GEN eNewsletters
Get the GEN Mobile App
Get GEN News from Alexa
Search
Home
Cancer
Multiple Myeloma
Multiple Myeloma
Latest
Latest
Featured posts
Most popular
7 days popular
By review score
Random
Multiple Myeloma
AbbVie to Co-Develop Teneobio’s Lead Candidate for Multiple Myeloma, Gains Acquisition Option
Multiple Myeloma
DNA/RNA Sequencing Offers Hope to Drug-Resistant Multiple Myeloma Patients
Multiple Myeloma
Patient Deaths Cited as Darzalex Combination Trials Halted
Multiple Myeloma
MorphoSys to Advance Pipeline, Platform Through Up-to-$150M U.S. IPO
Multiple Myeloma
Multiple Myeloma Patient Survival Associated with ADAR1 Enzyme Levels
Multiple Myeloma
A Cancer Cell’s Weight Predicts Its Therapeutic Opponent
Multiple Myeloma
Kite Pharma Submits IND for BCMA-Targeting CAR-T Cancer Immunotherapy
Multiple Myeloma
Janssen, Adaptive to Develop clonoSEQ for Measuring MRD in Darzalex-Treated MM
Multiple Myeloma
Liquid Biopsies Provide Patients with Less Painful Test for Multiple Myeloma
Multiple Myeloma
Stopping Myeloma in Its Tracks
Multiple Myeloma
A Mapping Service for the Cancer Genome
Multiple Myeloma
MorphoSys Regains MOR202 Rights as Celgene Collaboration Ends
Multiple Myeloma
MMRF Spearheads Effort to Speed Up Multiple Myeloma Drug Evaluation
Multiple Myeloma
GSK to Co-Develop Adaptimmune’s Lead Clinical Cancer Program in $350M+ Deal
Multiple Myeloma
Phase III Endpoints Met by Novartis, GSK/Theravance
Load more
Scroll Up
We use cookies to give you a better experience on genengnews.com. By continuing to use our site, you are agreeing to the use of cookies as set in our
privacy policy.
Got it!
Edit with Live CSS
![Researchers developed a RNA and DNA sequencing platform that benefits late-stage and drug-resistant multiple myeloma patients. [UCSF/Getty Images]](https://www.genengnews.com/wp-content/uploads/2018/08/Aug9_2018_Getty_507828431_MultipleMyeloma_6001086401541-265x198.jpg "DNA/RNA Sequencing Offers Hope to Drug-Resistant Multiple Myeloma Patients")
![Human myeloma cells grown in a bone marrow-like microenvironment. [UC San Diego Health]](https://www.genengnews.com/wp-content/uploads/2018/08/Dec6_2017_UCSDHealth_MyelomaCells8067232147-265x198.jpg "Multiple Myeloma Patient Survival Associated with ADAR1 Enzyme Levels")